JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Others

B6018 Disodium (R)-2-Hydroxyglutarate

Summary: inhibitor of α-ketoglutarate-dependent dioxygenases

insoluble in EtOH; insoluble in DMSO; ≥9.1 mg/mL
B1373 Phenformin HCl
1 Citation

Target: AMPK

Summary: biguanidine drug with anti-diabetic activity

≥12.1 mg/mL
B1858 Tranexamic Acid

Target: fibrinolysis

Summary: competitive inhibitor of plasminogen activation

insoluble in EtOH; insoluble in DMSO; ≥6.6 mg/mL
B3696 4EGI-1
2 Citation

Target: eIF4E/eIF3G interaction

Summary: Competitive eIF4E/eIF4G interaction inhibitor

≥22.56 mg/mL
B3697 4E1RCat

Target: eIF4F

Summary: Dual inhibitor of eIF4E:eIF4G and eIF4E:4E-BP1 interaction

≥23.85 mg/mL
A3183 Ansamitocin P-3

Target: Microtubules/Tubulins

Summary: Inhibitor of tublin spiralization,maytansine analog

≥31.75 mg/mL
A3384 Elacridar

Target: P-glycoprotein (P-gp)

Summary: BCRP inhibitor

≥56.4 mg/mL